Treatment and exacerbation in COPD subjects

Trial Identifier:	D589BR00039
Sponsor:	AstraZeneca
NCTID::	NCT03375450
Start Date:	June 2017
Primary Completion Date:	August 2019

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	London, United Kingdom

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.